FINAFLEX
Berberine
Avoid-flaggedObjective label signals
Flagged excipients
1
1 avoid · 0 caution
FDA recalls
0
no recall history
CAERS reports
1
FDA consumer events
Certifications
0
none recorded
1 avoid-level excipient · Every flag below links to the authority's published citation.
Supplement Facts
2 active ingredients| Ingredient | Amount | % DV |
|---|---|---|
| Berberine HCL BerberineUNII · 0I8Y3P32UF | 1000 mg | — |
| Bioperine Black PepperUNII · KM66971LVF | 10 mg | — |
Flagged excipients
1 flagged · authority citations
- ● AVOIDTitanium Dioxidecolor
Banned in EU food products effective 2022-08 (Commission Regulation (EU) 2022/63) following EFSA Panel opinion that a safe daily intake could not be established due to genotoxicity concerns. Still GRAS in the US under 21 CFR 73.575 but EU position is stricter.
FDA CAERS · adverse event context
1
consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.
CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →
Other ingredients
Hypromellose · Silica · Magnesium Stearate